Sensus Healthcare Reports 59% Revenue Decline in Q1 2026

Sensus Healthcare, Inc. reported a significant decline in financial performance for the first quarter of 2026, with revenues totaling $3.4 million, a decrease of 59% from $8.3 million in the same period last year. The company attributed this drop primarily to a reduced number of units sold, with only 10 units sold in the current quarter compared to 21 in the previous year. Additionally, some systems sold were under the Fair Deal Agreement program, which defers revenue recognition over the term of the agreement rather than at the time of shipment. The gross profit for the quarter was $1.0 million, down 77.3% from $4.4 million in the prior year, resulting in a gross profit margin of 29.4%, compared to 53.0% in the same quarter of 2025.

Operating expenses also decreased, totaling $5.3 million for the first quarter of 2026, down from $7.0 million in the prior year. This reduction was driven by lower general and administrative expenses, which fell to $2.0 million from $2.2 million, and a decrease in selling and marketing expenses, which dropped to $1.7 million from $2.2 million. Research and development expenses also saw a decline, totaling $1.6 million compared to $2.6 million in the previous year. Despite these reductions, the company reported a net loss of $2.6 million, slightly higher than the net loss of $2.6 million recorded in the first quarter of 2025.

In terms of operational developments, Sensus Healthcare continues to focus on its strategic initiatives, including the establishment of Sensus Healthcare Services, LLC, a subsidiary formed in February 2024 to provide operational healthcare services to dermatology clinics. The company is also navigating challenges related to customer concentration, with two U.S. customers accounting for 49% of revenue in the current quarter. The company’s cash and cash equivalents decreased to $18.3 million as of March 31, 2026, down from $22.1 million at the end of 2025, reflecting ongoing operational cash flow challenges.

Looking ahead, Sensus Healthcare's management remains cautious about the future, noting that the company’s operating results have historically exhibited seasonality, which can lead to fluctuations in revenue and profitability. The company is actively monitoring its liquidity position and capital requirements, with plans to potentially seek additional funding to support its operations and growth initiatives. The company’s ability to generate revenue and manage operating expenses will be critical in determining its financial health in the coming quarters.